CNR1 and Anxiety: We hypothesize that cortical injection of a peptide disrupting CB1R-DOR interactions or a drug specifically blocking this heteromer would prevent the decrease in DOR activity and concomitantly reduce the development of long-term anxiety in neuropathic animals.